Lei C, Chen J, Chen Z, Ma C, Chen X, Sun X
Front Pharmacol. 2025; 16:1449639.
PMID: 39959419
PMC: 11825820.
DOI: 10.3389/fphar.2025.1449639.
Ali S, Tallent J, Sambrook H, MacInnes D, Kinane C
BMJ Open. 2024; 14(10):e086149.
PMID: 39438102
PMC: 11499822.
DOI: 10.1136/bmjopen-2024-086149.
Farooq S, Hattle M, Kingstone T, Ajnakina O, Dazzan P, Demjaha A
Br J Psychiatry. 2024; 225(3):379-388.
PMID: 39101211
PMC: 11536189.
DOI: 10.1192/bjp.2024.101.
Vaswani-Bye A, McCain C, Blank J, Tennison M, Kopelovich S
Neuropsychiatr Dis Treat. 2024; 20:233-245.
PMID: 38348058
PMC: 10860596.
DOI: 10.2147/NDT.S432255.
Buck B, Wingerson M, Whiting E, Snyder J, Monroe-DeVita M, Ben-Zeev D
JMIR Ment Health. 2023; 10:e50522.
PMID: 38032692
PMC: 10722359.
DOI: 10.2196/50522.
Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study.
Matsuzaki H, Hatano M, Iwata M, Saito T, Yamada S
Neuropsychiatr Dis Treat. 2023; 19:615-622.
PMID: 36945253
PMC: 10024870.
DOI: 10.2147/NDT.S402945.
The Lived Experiences of Family Members and Carers of People with Psychosis: A Bottom-Up Review Co-Written by Experts by Experience and Academics.
Estrade A, Onwumere J, Venables J, Gilardi L, Cabrera A, Rico J
Psychopathology. 2023; 56(5):371-382.
PMID: 36689938
PMC: 10568611.
DOI: 10.1159/000528513.
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes.
Howes O, Cummings C, Chapman G, Shatalina E
Neuropsychopharmacology. 2022; 48(1):151-167.
PMID: 36056106
PMC: 9700830.
DOI: 10.1038/s41386-022-01426-x.
Descriptive outcomes for a cohort of high-frequency psychiatric service users in the Western Cape, South Africa after 10 years.
Coetzee D, Koen L, Niehaus D, Botha U
S Afr J Psychiatr. 2022; 28:1821.
PMID: 35747340
PMC: 9210150.
DOI: 10.4102/sajpsychiatry.v28i0.1821.
Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia.
Farooq S, Hattle M, Dazzan P, Kingstone T, Ajnakina O, Shiers D
BMJ Open. 2022; 12(4):e056420.
PMID: 35396294
PMC: 8996048.
DOI: 10.1136/bmjopen-2021-056420.
Peer supported Open Dialogue in the National Health Service: implementing and evaluating a new approach to Mental Health Care.
Kinane C, Osborne J, Ishaq Y, Colman M, MacInnes D
BMC Psychiatry. 2022; 22(1):138.
PMID: 35193551
PMC: 8862567.
DOI: 10.1186/s12888-022-03731-7.
Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study.
Dubreucq J, Gabayet F, Godin O, Andre M, Aouizerate B, Capdevielle D
Schizophr Bull. 2021; 48(2):382-394.
PMID: 34718808
PMC: 8886587.
DOI: 10.1093/schbul/sbab114.
Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine.
Fitzgerald I, ODwyer S, Brooks M, Sahm L, Crowley E, Ni Dhubhlaing C
Front Psychiatry. 2021; 12:730769.
PMID: 34557121
PMC: 8453003.
DOI: 10.3389/fpsyt.2021.730769.
Overview and Use of Tools for Selecting Modelling Techniques in Health Economic Studies.
Jin H, Robinson S, Shang W, Achilla E, Aceituno D, Byford S
Pharmacoeconomics. 2021; 39(7):757-770.
PMID: 34013440
DOI: 10.1007/s40273-021-01038-1.
Schizophrenia outcomes in the 21st century: A systematic review.
Huxley P, Krayer A, Poole R, Prendergast L, Aryal S, Warner R
Brain Behav. 2021; 11(6):e02172.
PMID: 33991072
PMC: 8213926.
DOI: 10.1002/brb3.2172.
Specialised early intervention teams (extended time) for recent-onset psychosis.
Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B, Harrison R
Cochrane Database Syst Rev. 2020; 11:CD013287.
PMID: 33135812
PMC: 8094422.
DOI: 10.1002/14651858.CD013287.pub2.
Specialised early intervention teams for recent-onset psychosis.
Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B, Harrison R
Cochrane Database Syst Rev. 2020; 11:CD013288.
PMID: 33135811
PMC: 8092671.
DOI: 10.1002/14651858.CD013288.pub2.
Prevalence of treatment resistance and clozapine use in early intervention services.
Stokes I, Griffiths S, Jones R, Everard L, Jones P, Fowler D
BJPsych Open. 2020; 6(5):e107.
PMID: 32938513
PMC: 7576650.
DOI: 10.1192/bjo.2020.89.
Carer subjective burden after first-episode psychosis: Types and predictors. A multilevel statistical approach.
Charles S, Kirkbride J, Onwumere J, Lyons N, Man L, Floyd C
Int J Soc Psychiatry. 2020; 67(1):73-83.
PMID: 32522056
PMC: 8191154.
DOI: 10.1177/0020764020930041.
Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.
Lyngstad S, Gardsjord E, Engen M, Haatveit B, Ihler H, Wedervang-Resell K
Eur Arch Psychiatry Clin Neurosci. 2020; 270(6):709-722.
PMID: 32130475
PMC: 7423800.
DOI: 10.1007/s00406-020-01112-3.